Analysis of stress and sleep hormones in the nursing team that works the day after receiving massage to control symptoms and ways to cope with stress, pain and sleep: a randomized clinical trial

Not Applicable

• Conditions: F02.830.855; Psychological stress. Physiological stress. Sleep. Pain.; G07.775; F01.145.126.990; C23.888.592.612

• Registration Number: RBR-3bjjf4
• Lead Sponsor: Escola de Enfermagem da Universidade de São Paulo

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-11-13
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruitment completed
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

Women aged 20 to 45 years; sleep period performed totally in the dark; belonging to the morning shift; score of 40 or more from the List of Stress Symptoms; working time in the hospital between one and three years; return of vacation or medical leave after 30 days.

Exclusion Criteria

Smoking; hypertensive; use of beta-blockers, glucocorticoids, psychotropic and anxiolytics; pregnant women;
hysterectomized; professionals with holidays marked or on medical leave during the research period; early use of the previous drugs in the collection period; up to four sessions of other integrative practices two months ago; of integrative practices (during the period of data collection.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Application of six massage sessions, twice a week, with a 15-minute period each session, there was a statistically significant reduction, with p-value less than 0.0001 by the list of stress signs and symptoms, as well as salivary cortisol analysis, demonstrated by AUC (area under the curve, showing daily cortisol secretion values) showed p-value of 0.002. By Cohen's d-test, the effect size was 1.21 (means a very large effect).<br>

Secondary Outcome Measures

Name	Time	Method
Sleep: Improvement of sleep quality, assessed before and after in the groups, with a significance level of 5%, determined by the Pittsburgh Sleep Quality Index and urinary melatonin (6-6-sulfatoxymelatonin) analysis.;Pain: Reduction of the impact of pain on components of the Brief Pain Index, evaluated before and after in the groups, with significance level of 5%.;Outcome sleep.<br>Among the seven sleep assessment components determined by the Pittsburgh Sleep Quality Index and the total value, there was a statistically significant difference by the analysis of mixed effects between groups for sleep latency (p less than 0.001) and the total score (p equal 0.009). There was no statistically significant difference in 6-6-sulfatoxymelatonin values.;Outcome pain.<br>There was a statitically significant difference in the components of the Brief Pain Index: general activity and work with p value less than 0.001 and mood and sleep with p value less than 0.05.